No mismatch between circulating flu strains and vaccine strains
Low influenza vaccine uptake in India despite high mortality rates; manufacturers scaling up production to meet growing ...
DARZALEX Continues to Redefine Multiple Myeloma Treatment with Robust Market Performance | DelveInsight
DelveInsight's "DARZALEX Market Size, Forecast, and Market Insight Report" highlights the details around DARZALEX, a human ...
Medscape3d
Upadacitinib Dosing for AD Can Be Increased or Decreased Depending on Response
A treat-to-target study of upadacitinib in atopic dermatitis showed that dosing can be adjusted depending on early patient ...
Medindia5d
Low Doses of Antibiotic Work Just as Well as Higher Ones to Treat Rare Type of Chronic Hair Loss
Small amounts of a common antibiotic and anti-inflammatory drug can curb symptoms where a misplaced immune reaction (e.g.,�autoimmunity) can cause permanent hair loss, a new study shows. This regimen ...
Medscape6d
Can Six Shots a Year Keep Hemophilia Bleeding Away?
Treatment involved an antithrombin-based dose regimen targeting antithrombin levels between 15% and 35%, starting at 50 mg ...
Curevo Raises $110 Million to Advance Amezosvatein Shingles Vaccine
Amezosvatein has shown excellent immunogenicity and improved tolerability in Phase 2 study -- Medicxi leads round, joined by new investors ...
Pharmabiz6d
Sanofi adopts US FDA-selected flu strains to ensure readiness for the 2025-26 flu season
Sanofi adopts US FDA-selected flu strains to ensure readiness for the 2025-26 flu season: Bridgewater, New Jersey Monday, March 17, 2025, 14:00 Hrs [IST] Sanofi announced the imme ...